CD11b+ and sca-1+ cells exert the main beneficial effects of systemically administered bone marrow-derivedmononuclear cells in a murinemodel of mixed Th2/Th17 allergic airway inflammation
Systemic administration of bone marrow-derived mononuclear cells (BMDMCs) or bone marrowderivedmesenchymal stromal cells (MSCs) reduces inflammation and airway hyperresponsiveness (AHR) in amurinemodel of Th2-mediated eosinophilic allergic airway inflammation. However, since BMDMCs are a heterogeneous population that includesMSCs, it is unclearwhether theMSCs alone are responsible for the BMDMC ef